Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Bi

Showing results (281-290 of 284) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 284 results.
Cancer Medicine|July 16, 2019
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trialFeng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Cancer Medicine|December 21, 2016
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trialFeng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Lancet (London, England)|April 22, 2018
The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy ChinaJun Yang, José G Siri, Justin V Remais, et al.
National Science Review|December 31, 2025
Ultrahigh-energy gamma-ray emission associated with black hole-jet systemsZhen Cao, Felix Aharonian, Yun-Xiang Bai, et al.
Pageof 29

Showing results (281-290 of 284) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 284 results.
Cancer Medicine|July 16, 2019
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trialFeng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Cancer Medicine|December 21, 2016
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trialFeng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Lancet (London, England)|April 22, 2018
The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy ChinaJun Yang, José G Siri, Justin V Remais, et al.
National Science Review|December 31, 2025
Ultrahigh-energy gamma-ray emission associated with black hole-jet systemsZhen Cao, Felix Aharonian, Yun-Xiang Bai, et al.
Pageof 29